UNSPSC 51341701: Kethoxal or ketoxal

This classification denotes an antiviral agent with the molecular formula C6H12O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E00MDP82S4, chemically known as 3-ethoxy-1,1-dihydroxy-2-butanone but generally known as kethoxal, which bears US NIH Compound Identifier 34006. European Medicines Agency schedules Ketoxal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08379MIG.

The term KETOXAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). Kethoxal or ketoxal bears US NLM identifiers UMLS ID C0064305 and NCI Concept Code C83855. SMILES: CCOC(C)C(=O)C(O)O.

UNSPSC 51341701 Kethoxal or ketoxal is a Commodity code that nominally targets a specific chemical compound, but recent state and local solicitations do not reflect procurement of kethoxal itself. Instead, the code appears to be applied—likely in error—to broader pharmaceutical and medical supply acquisitions that fall outside the scope of a single chemical product. The opportunities tagged to this code include general naloxone procurement, pharmacy benefit program administration, emergency medical supplies for fire departments, and generic pharmaceutical distribution through cooperative purchasing vehicles, none of which involve kethoxal as an active ingredient or product line. State and local governments issuing under this code span county health departments, municipal fire services, state health and human services commissions, and multistate cooperative purchasing alliances; Seminole County, Florida; the City of Tampa; Texas Health and Human Services Commission; and the Minnesota Department of Administration (administering MMCAP) appear in the recent record.

Geographic activity centers on Florida, Texas, and Minnesota, with MMCAP's reach extending to Oregon and other participating jurisdictions. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually, posted June 30, 2026, due July 26, 2023); the City of Tampa's IFB for medical and first aid supplies for its Fire Department Rescue Division (169 line items, $700,000 estimated contract value, posted March 25, 2026, due March 13, 2026, sheltered as a certified Small Local Business Enterprise opportunity with a 5% bid discount); Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, due March 26, 2026). The code shows minimal alignment with its stated commodity definition and warrants clarification on taxonomy application before pursuing opportunities under this classification.